Modification of sialyl residues of sialoglycoprotein(s) of the human erythrocyte surface.
D000017:ABO Blood-Group System; D000081:Acetamides; D001665:Binding Sites; D001894:Borohydrides / Q000494:pharmacology*; D002462:Cell Membrane / Q000032:analysis / Q000187:drug effects; D004591:Electrophoresis, Polyacrylamide Gel; D004912:Erythrocytes / Q000032:analysis / Q000187:drug effects* / Q000276:immunology; D006023:Glycoproteins / Q000032:analysis*; D006385:Hemagglutination Inhibition Tests; D006801:Humans; D037102:Lectins; D008055:Lipids / Q000032:analysis; D009438:Neuraminic Acids / Q000032:analysis* / Q000302:isolation & purification; D009439:Neuraminidase; D010084:Oxidation-Reduction; D010504:Periodic Acid / Q000494:pharmacology*; D012964:Sodium / Q000494:pharmacology; D013400:Sugar Acids; D014316:Tritium
D000017:ABO Blood-Group System; D000081:Acetamides; D001894:Borohydrides; D006023:Glycoproteins; D037102:Lectins; D008055:Lipids; D009438:Neuraminic Acids; D013400:Sugar Acids; D014316:Tritium; D010504:Periodic Acid; D012964:Sodium; D009439:Neuraminidase